| Market Capitalization (Millions $) |
49 |
| Shares
Outstanding (Millions) |
13 |
| Employees |
3 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-9 |
| Cash Flow (TTM) (Millions $) |
2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Lixte Biotechnology Holdings Inc is a biopharmaceutical company based in East Setauket, New York. It focuses on developing novel drugs for the treatment of various cancers. The company's primary focus is on developing inhibitors of protein phosphatases, which are involved in regulating critical signaling pathways in cancer cells. Lixte Biotechnology aims to identify and develop targeted therapies that can potentially improve the outcomes of cancer patients. The company's research and development efforts primarily involve preclinical studies and early-stage clinical trials to evaluate the safety and efficacy of its drug candidates.
Company Address: 433 Plaza Real Boca Raton 33432 FL
Company Phone Number: 830-7092 Stock Exchange / Ticker: NASDAQ LIXT
|
1.88%